Splanchnic Mesoderm Differentiation With Timed Signaling Control

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need for improved methods of differentiating mesoderm subtypes from pluripotent stem cells to produce organoids for genetics, drug screening, personalized medicine, and transplantation, addressing disruptions in embryonic development that can lead to congenital birth defects.

Innovation Solution

Methods involving the use of signaling pathway inhibitors and activators, such as TGF-beta, Wnt, BMP, FGF, and retinoic acid, to differentiate pluripotent stem cells into specific mesoderm subtypes like retinoic acid-responsive lateral plate mesoderm cells, splanchnic mesoderm cells, and others, through controlled exposure times and combinations of signaling molecules.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional differentiation methods are used, then mesoderm cells can be produced, but the differentiation precision and cell type specificity are insufficient

Engineering Contradiction:

Improvedifferentiation precisionVSAvoidmethod complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The differentiation process is divided into sequential stages: primitive streak formation, lateral plate mesoderm differentiation, and splanchnic mesoderm specification. Each stage uses specific signaling pathway modulators (TGF-beta inhibitors, Wnt inhibitors, BMP activators) applied for defined time periods to achieve precise temporal control over cell fate decisions.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The method employs dynamic adjustment of signaling pathway activity parameters through controlled addition and removal of modulators at specific time points. Concentration gradients and exposure durations are precisely optimized to direct differentiation toward specific mesoderm subtypes while preventing unwanted lineage commitments.

Inventive Principle:

Principle #35Parameter changes

2Manufacturing precision

If multiple signaling pathway modulators are used to improve differentiation control, then cell type specificity increases, but the process complexity and optimization difficulty increase

Engineering Contradiction:

Improvecell type specificityVSAvoidprocess optimization

Core Design Contradiction:

Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The protocol pre-establishes the sequence and timing of modulator additions based on the known embryonic development timeline. Primitive streak formation is induced first, followed by lateral plate mesoderm specification, then splanchnic mesoderm differentiation. This predetermined sequence simplifies execution while maintaining high specificity.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

Small molecule modulators serve as intermediaries to precisely control signaling pathway activity without requiring complex genetic manipulation. These chemical agents provide reversible, titratable control over differentiation outcomes, enabling fine-tuning of cell fate decisions through concentration and timing adjustments.

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS20260002121A1Improved methods of preparing different mesoderm cell types

Publication Date: 2026.01.01 RIKEN CO LTD

AI summary

Disclosed herein are improved in vitro methods of making splanchnic mesoderm cell types and subtypes thereof from pluripotent cells. These methods can be used to produced improved foregut- and hindgut-derived organoids containing enriched mesenchyme, which enhances organoid viability, growth, and maturation, both in in vitro culture and in vivo transplantation.